Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Early opportunity to invest in a Nevada lithium project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Small Pharma V.DMT

Alternate Symbol(s):  DMTTF

Healthcare Biotechnology
Small Pharma Inc is a neuropharmaceutical company. It is committed towards the development of effective therapeutic treatments for mental health disorders. Small Pharma is developing N,N-dimethyltryptamine and a pipeline of novel patent-protected deuterium-enriched tryptamine compounds in combination with psychotherapy as potential rapid onset, sustained treatments for depression and other mental health disorders.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (TSXV:DMT)

Fundamentals Snapshot (TSXV:DMT)

Current News (TSXV:DMT)

Small Pharma Announces Significant Developments In Intellectual Property Portfolio

GlobeNewswire 10 days ago

Small Pharma to Present at Upcoming CINP World Congress of Neuropsychopharmacology

GlobeNewswire May 3, 2023

Small Pharma Announces Positive Six-month Data from Phase IIa Trial of SPL026

GlobeNewswire April 4, 2023

Small Pharma to Host Virtual Roundtable Event with Key Opinion Leaders in Psychiatry

GlobeNewswire March 7, 2023

Small Pharma Announces Further Positive Data from SPL026 Phase IIa Trial in Major Depressive Disorder Strengthening Topline Efficacy Results

GlobeNewswire March 7, 2023

Small Pharma to Present at Cowen's 43rd Annual Health Care Conference

GlobeNewswire March 1, 2023

First Subject Dosed in Small Pharma's First-in-Human Phase I Clinical Trial with SPL028

GlobeNewswire February 15, 2023

Small Pharma (TSXV:DMT) adds two new patents to its portfolio approved for issue

Jon Brown February 1, 2023

Small Pharma Announces Update on Intellectual Property Portfolio with Two New Patents Approved for Issue

GlobeNewswire February 1, 2023
View More News ››

Opinion & Analysis (TSXV:DMT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSXV:DMT)

Small Pharma receives OK for 2 U.S. patents

Small Pharma receives OK for 2 U.S. patents   2023-02-01 09:59 ET - News Release   Mr. George Tziras reports SMALL...
GillRipper - February 4, 2023

Small Pharma has Nov. 30 cash position of $22.7-million

Small Pharma has Nov. 30 cash position of $22.7-million   2023-01-25 12:03 ET - News Release   Mr. George Tziras...
GillRipper - February 4, 2023

Corporate Presentation

https://smallpharma.com/wp-content/uploads/2023/01/Small-Pharma-Corporate-Presentation-25-Jan.pdf Kind Regards To All Gilly
GillRipper - February 1, 2023

RE:RE:Price Target Raised

https://www.medicalgold.ca/posts/top-psychedelic-clinical-trials-in-2023 Kind Regards To All Gilly
GillRipper - January 30, 2023

RE:Price Target Raised

Looks like the companies share buy back bid (236k) sitting there at 13.5....JMO. Kind Regards To All Gilly
GillRipper - January 27, 2023

Price Target Raised

https://efhuttongroup.bluematrix.com/links2/html/1c2b91ac-8826-4cd7-8bde-07899276d305 https://microdose.buzz/news/small-pharma-phase-2a...
GillRipper - January 26, 2023
View more Bullboard ››

Royalties Inc.

Royalties Inc.

Royalties Inc. is focused on seeking cash flow generating royalty opportunities in various industries. While the Issuer’s ...
View More »